RITAZAREM (GPA)

Full Name: An International, Open Label, Randomized Controlled Trial Comparing Rituximab with Azathioprine as Maintenance Therapy in Relapsing ANCA-associated Vasculitis
Study Dates: 2012-2020
NCT #: NCT01697267
Study Findings: This study demonstrated that patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, with a prior history of relapse, who receive maintenance therapy with rituximab are more likely to remain in remission than those given azathioprine.